|
|
Researchers terminate trial examining aliskiren in high-risk patients - Endocrine Today |
Endocrine Today
Novartis recently announced its decision to halt a trial assessing the safety and efficacy of aliskiren for treatment of hypertension in patients with type 2 diabetes and renal impairment who are at high risk for cardiovascular and renal events,
|
|
|
Franciscan opening East Side Tacoma kidney dialysis center - TheNewsTribune.com |
TheNewsTribune.com
Tacoma's Franciscan Health System is broadening its reach for kidney dialysis patients with the opening of its fourth dialysis center in Pierce County in mid-January. Tacoma's Franciscan Health System is broadening its reach for kidney dialysis
|
|
JAMA commentary contends vitamin therapy can still reduce stroke - EurekAlert (press release) |
EurekAlert (press release)
He says two key issues have been overlooked in the interpretation of the clinical trials: the key role of vitamin B12, and the newly recognized role of renal failure. "It is now clear that the large trials showing no benefit of vitamin therapy obscured
|
|
In deciding who to vote for in the 2012 presidential election, how important ... - Renal and Urology News |
|
Shares of NxStage Medical Under Pressure, Down 3.7% - Financial News Network Online |
Financial News Network Online
NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company's primary product, the NxStage System One, is a small,
|
|
|
|
|
<< Start < Prev 561 562 563 564 565 566 567 568 569 570 Next > End >>
|
|
Page 566 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
